GILEAD | GLOBAL PATIENT SOLUTIONS Trademark Information
Number:
2320228
Ir number:
1700601
Words:
GILEAD | GLOBAL PATIENT SOLUTIONS
Images:
Kind:
Figurative
Status group:
REMOVED
Status code:
Cancelled
Status detail:
Cancelled at the request of IB
Priority date:
09 Feb 2022
Lodgement date:
27 Jul 2022
Ir notification date:
08 Dec 2022
Ir renewal due date:
27 Jul 2032
First report date:
03 Jan 2023
Acceptance date:
26 Aug 2024
Acceptance advertised date:
26 Aug 2024
Entered on register date:
04 Nov 2024
Registered from date:
27 Jul 2022
Registration advertised date:
04 Nov 2024
Renewal due date:
27 Jul 2032
Filing date:
27 Jul 2022
Ir contact:
, , Cynthia Smuzynska Gilead Sciences, Inc., , Array
Indexing constituents:
GILEAD, |, GLOBAL, PATIENT, SOLUTIONSClass:
41
Endorsements:
Customer description:
The mark consists of a design of a shield and leaf, both shaded with red, to the left of the word "GILEAD" in gray, which is to the left of a gray vertical line. On the other side of the line appears the words "GLOBAL PATIENT SOLUTIONS" in gray under a red, orange, green, and blue sketched drawing of persons running while holding hands.
The color(s) red, gray, orange, green, and blue is/are claimed as a feature of the mark.. The mark consists of a design of a shield and leaf, both shaded with red, to the left of the word "GILEAD" in gray, which is to the left of a gray vertical line. On the other side of the line appears the words "GLOBAL PATIENT SOLUTIONS" in gray under a red, orange, green, and blue sketched drawing of persons running while holding hands.. Provisions of paragraph 44(3)(b) and/or Reg 4.15A(3)(b) applied.
Convention details:
Array
Mark categories:
Trademark
Registration date:
2024-11-04
Last status check:
2026-06-19 22:14:58
Status updated at:
2026-06-19 22:14:58
Goods and services:
1) Class: 41Description: Conducting educational events, course, tutorials and seminars regarding prevention, treatment and diagnosis of diseases and disorders in the fields of oncology, virology, cell therapy, hepatology, hematology and inflammation and the dissemination of materials in connection therewith, providing educational information and publication of texts, other than publicity texts, to promote public awareness in the field of treatment, diagnosis and prevention of diseases and disorders in the fields of oncology, virology, cell therapy, hepatology, hematology and inflammation.
History and publication details:
1) Date: 2025-11-20
Display name: Status change to Voided
2) Date: 2024-11-05
Display name: International Registration in Australia Protected After Adverse (No amendments) correspondence sent
3) Date: 2024-11-04
Display name: International Registration in Australia Protected After Adverse (No amendments) correspondence sent
4) Date: 2024-11-04
Display name: IP Right Registration Published
5) Date: 2024-11-04
Display name: Status change to Registered/Protected
6) Date: 2024-08-27
Display name: Application Accepted correspondence sent
7) Date: 2024-08-26
Display name: Application Accepted correspondence sent
8) Date: 2024-08-26
Display name: IP Right has been Examined
9) Date: 2024-08-26
Display name: IP Right Acceptance Published
10) Date: 2024-08-26
Display name: Status change to Accepted
11) Date: 2024-08-26
Display name: Terminate Deferral
12) Date: 2024-08-26
Display name: Examination Response Received
13) Date: 2024-04-29
Display name: General Correspondence sent
14) Date: 2024-04-29
Display name: Deferment of Acceptance
Description: Deferral Period: 6 months Time remaining to accept: 10 days Reasons for deferral: Gathering evidence for honest concurrent use, prior use or other circumstances;
Previous details:
New details:
15) Date: 2024-04-23
Display name: Deferral of Acceptance Requested
16) Date: 2024-04-03
Display name: Extension of Time Granted correspondence sent
17) Date: 2024-04-03
Display name: Extension of Time Granted
18) Date: 2024-04-03
Display name: Extension of Time Requested
19) Date: 2024-01-24
Display name: Adverse Report (Examination) correspondence sent
20) Date: 2024-01-24
Display name: IP Right has been Examined
21) Date: 2024-01-15
Display name: Examination Response Received
22) Date: 2023-12-09
Display name: IRDA - Opposition Still Possible Notice correspondence sent
23) Date: 2023-01-25
Display name: Customer Amendment Made correspondence sent
24) Date: 2023-01-24
Display name: Amendment to Address for Service Requested
25) Date: 2023-01-04
Display name: Adverse Report (Examination) correspondence sent
26) Date: 2023-01-03
Display name: IP Right has been Examined
27) Date: 2022-12-16
Display name: Examination expedited
28) Date: 2022-12-16
Display name: Awaiting examination
29) Date: 2022-12-16
Display name: Word and image indexing completed
30) Date: 2022-12-08
Display name: IP Right Filed Published
31) Date: 2022-12-08
Display name: Status change to Published
32) Date: 2022-12-08
Display name: Status change to Filed
33) Date: 2022-12-08
Display name: Application Received
34) Date: 2022-12-08
Display name: IP right goods and service classes updated
Description: Class Count: 1 Class Numbers:41
Previous details: Class Count: 0 Class Numbers:
New details: Class Count: 1 Class Numbers: 41
35) Date: 2022-12-08
Display name: IP Right Goods and Services Items updated
Description: Class Number: 41
Previous details:
New details: Class Number: 41 Class Items: Conducting educational events, course, tutorials and seminars regarding prevention, treatment and diagnosis of diseases and disorders in the fields of oncology, virology, cell therapy, hepatology, hematology and inflammation and the dissemination of materials in connection therewith; providing educational information and publication of texts, other than publicity texts, to promote public awareness in the field of treatment, diagnosis and prevention of diseases and disorders in the fields of oncology, virology, cell therapy, hepatology, hematology and inflammation.
36) Date: 2022-12-08
Display name: Status change to Received
37) Date: 2022-12-08
Display name: Trade mark representation updated
Display name: Status change to Voided
2) Date: 2024-11-05
Display name: International Registration in Australia Protected After Adverse (No amendments) correspondence sent
3) Date: 2024-11-04
Display name: International Registration in Australia Protected After Adverse (No amendments) correspondence sent
4) Date: 2024-11-04
Display name: IP Right Registration Published
5) Date: 2024-11-04
Display name: Status change to Registered/Protected
6) Date: 2024-08-27
Display name: Application Accepted correspondence sent
7) Date: 2024-08-26
Display name: Application Accepted correspondence sent
8) Date: 2024-08-26
Display name: IP Right has been Examined
9) Date: 2024-08-26
Display name: IP Right Acceptance Published
10) Date: 2024-08-26
Display name: Status change to Accepted
11) Date: 2024-08-26
Display name: Terminate Deferral
12) Date: 2024-08-26
Display name: Examination Response Received
13) Date: 2024-04-29
Display name: General Correspondence sent
14) Date: 2024-04-29
Display name: Deferment of Acceptance
Description: Deferral Period: 6 months Time remaining to accept: 10 days Reasons for deferral: Gathering evidence for honest concurrent use, prior use or other circumstances;
Previous details:
New details:
15) Date: 2024-04-23
Display name: Deferral of Acceptance Requested
16) Date: 2024-04-03
Display name: Extension of Time Granted correspondence sent
17) Date: 2024-04-03
Display name: Extension of Time Granted
18) Date: 2024-04-03
Display name: Extension of Time Requested
19) Date: 2024-01-24
Display name: Adverse Report (Examination) correspondence sent
20) Date: 2024-01-24
Display name: IP Right has been Examined
21) Date: 2024-01-15
Display name: Examination Response Received
22) Date: 2023-12-09
Display name: IRDA - Opposition Still Possible Notice correspondence sent
23) Date: 2023-01-25
Display name: Customer Amendment Made correspondence sent
24) Date: 2023-01-24
Display name: Amendment to Address for Service Requested
25) Date: 2023-01-04
Display name: Adverse Report (Examination) correspondence sent
26) Date: 2023-01-03
Display name: IP Right has been Examined
27) Date: 2022-12-16
Display name: Examination expedited
28) Date: 2022-12-16
Display name: Awaiting examination
29) Date: 2022-12-16
Display name: Word and image indexing completed
30) Date: 2022-12-08
Display name: IP Right Filed Published
31) Date: 2022-12-08
Display name: Status change to Published
32) Date: 2022-12-08
Display name: Status change to Filed
33) Date: 2022-12-08
Display name: Application Received
34) Date: 2022-12-08
Display name: IP right goods and service classes updated
Description: Class Count: 1 Class Numbers:41
Previous details: Class Count: 0 Class Numbers:
New details: Class Count: 1 Class Numbers: 41
35) Date: 2022-12-08
Display name: IP Right Goods and Services Items updated
Description: Class Number: 41
Previous details:
New details: Class Number: 41 Class Items: Conducting educational events, course, tutorials and seminars regarding prevention, treatment and diagnosis of diseases and disorders in the fields of oncology, virology, cell therapy, hepatology, hematology and inflammation and the dissemination of materials in connection therewith; providing educational information and publication of texts, other than publicity texts, to promote public awareness in the field of treatment, diagnosis and prevention of diseases and disorders in the fields of oncology, virology, cell therapy, hepatology, hematology and inflammation.
36) Date: 2022-12-08
Display name: Status change to Received
37) Date: 2022-12-08
Display name: Trade mark representation updated
Owner Information
Owner structured address:
333 Lakeside Drive Foster City CA 94404, UNITED STATES OF AMERICA
Owner is private:
0
Service Information
Address Abn:
13613954368
Address structured address:
Level 4 7 Macquarie Place, Sydney, NSW, AUSTRALIA, Postal Code: 2000
Address is private:
0